Current Price Status
Stock in Weak Growth Expectation
Stock is currently in distressed situation that the market is pricing a worse than industry average negative annual earning growth.
Stock in this situation can be good bargain if the stock beats the weak growth expectation or it can be long-term downtrend if the weak earning growth remains for a while.
Company is in Positive Earning
- MGRC current price is 75.93% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedMGRC past 5-day return perform better than Commercial Services industry average return by 4.52%
Above 30-Day AverageCurrent price RM1.08 is above than 30-day average RM0.96 by 12.5%
|Return (%)||MGRC||Commercial Services|
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Potential Better Revenue Growth
MGRC posted a better revenue growth than average in the recent quarter.
Continued Losing Money
MGRC has been losing money in the 4 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
MGRC recent daily traded volume is -35.71% lower than past month average.
|Past 30-Day||Past 5-Day|
|84k daily||54k daily|
Price History Chart
Past 30-day Average Price: RM0.96
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stocks that has more than two consecutive money-losing quarters
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Stock Company Profile
MSIAN GENOMICS RES CENTRE BHD
Malaysian Genomics Resource Centre Bhd. is an investment holding company, which engages in the provision of laboratory services. It focuses on the genome sequencing and analysis, genetic screening services, and pathology services. The company was founded by Robert George Hercus and Munirah binti Haji Abdul Hamid on May 18, 2004 and is headquartered in Kuala Lumpur, Malaysia.